Call Options

5 transactions
Quarter Operation Price Per call calls change calls Held SEC Form
Q2 2022

Aug 15, 2022

BUY
$9.95 - $12.27 $45,770 - $56,442
4,600 Added 22.55%
25,000 $262,000
Q1 2022

May 16, 2022

SELL
$9.81 - $15.4 $192,276 - $301,840
-19,600 Reduced 49.0%
20,400 $222,000
Q2 2021

Aug 16, 2021

BUY
$12.97 - $16.15 $259,400 - $323,000
20,000 Added 100.0%
40,000 $572,000
Q1 2021

May 17, 2021

BUY
$13.59 - $18.54 $67,950 - $92,700
5,000 Added 33.33%
20,000 $279,000
Q4 2020

Feb 16, 2021

BUY
$14.3 - $18.74 $214,500 - $281,100
15,000 New
15,000 $281,000

Others Institutions Holding VTRS

About Viatris Inc


  • Ticker VTRS
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 1,212,669,952
  • Market Cap $15.8B
  • Description
  • Viatris Inc. operates as a healthcare company worldwide. The company operates in four segments: Developed Markets, Greater China, JANZ, and Emerging Markets. It offers prescription brand drugs, generic drugs, complex generic drugs, biosimilars, and active pharmaceutical ingredients (APIs). The company offers drugs in various therapeutic areas, i...
More about VTRS
Track Bill Miller's Portfolio

Track Bill Miller Portfolio

Follow Bill Miller (Miller Value Partners, LLC) and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Miller Value Partners, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Miller Value Partners, LLC and Bill Miller with notifications on news.